• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于治疗肝硬化继发难治性腹水或静脉曲张出血的原发性经颈静脉肝内门体分流术。

Primary constrained TIPS for treating refractory ascites or variceal bleeding secondary to hepatic cirrhosis.

作者信息

Rabei R, Mathevosian S, Tasse J, Madassery S, Arslan B, Turba U, Ahmed O

机构信息

1 Chicago Medical School , Rosalind Franklin University , North Chicago, IL , USA.

2 Rush University Medical Center , Chicago, IL , USA.

出版信息

Br J Radiol. 2018 Feb;91(1083):20170409. doi: 10.1259/bjr.20170409. Epub 2017 Dec 15.

DOI:10.1259/bjr.20170409
PMID:29166137
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5965479/
Abstract

OBJECTIVE

To report an initial experience using a primary constrained transjugular intrahepatic portosystemic shunt (TIPS) technique for treating cirrhotic patients with refractory ascites or variceal bleeding.

METHODS

All patients undergoing primary constrained (n = 9) and conventional (n = 18) TIPS between July 2014 and June 2016 were retrospectively reviewed. Preprocedure demographics, Child-Pugh, model for end-stage liver disease and technical variables were recorded. Outcomes measured included technical and clinical success, complications, 30-day mortality, as well as necessity for TIPS revision. Average (SD) and median follow-up was 237 (190) and 226 days.

RESULTS

All constrained and conventional TIPS were technically successful (100%). Clinical success as defined as a reduction or improvement in presenting symptoms was 88.9% (8/9) and 100% (18/18) in the constrained and conventional groups, respectively (p = 1). The average reduction in portosystemic gradient was lower in the constrained group, 6.1 mmHg compared with 10.6 mmHg in the conventional group (p = 0.73). The rate of hepatic encephalopathy following TIPS placement was higher in the conventional group [16.7% (3/18)] compared with 0% in the constrained group (p = 0.52). The percentage of patients requiring TIPS revision was lower in the constrained group, although the results were not significant (11.1 vs 22.2%, p = 0.63).

CONCLUSION

Primary constrained TIPS is a feasible modification to conventional TIPS with similar technical and clinical success rates. A trend towards a smaller reduction in the portosystemic gradient and need for revision was observed in the constrained group. Advances in knowledge: Primary constrained TIPS allows for greater stepwise control over shunt diameter and may represent an improved technique for patients at risk for hepatic encephalopathy.

摘要

目的

报告使用原发性限制性经颈静脉肝内门体分流术(TIPS)治疗肝硬化难治性腹水或静脉曲张出血患者的初步经验。

方法

回顾性分析2014年7月至2016年6月期间接受原发性限制性(n = 9)和传统(n = 18)TIPS治疗的所有患者。记录术前人口统计学、Child-Pugh评分、终末期肝病模型及技术变量。测量的结果包括技术和临床成功率、并发症、30天死亡率以及TIPS修正的必要性。平均(标准差)和中位随访时间分别为237(190)天和226天。

结果

所有限制性和传统TIPS在技术上均成功(100%)。以症状减轻或改善定义的临床成功率在限制性组和传统组分别为88.9%(8/9)和100%(18/18)(p = 1)。限制性组门体压力梯度的平均降低幅度较低,为6.1 mmHg,而传统组为10.6 mmHg(p = 0.73)。TIPS置入后传统组肝性脑病发生率[16.7%(3/18)]高于限制性组的0%(p = 约0.52)。限制性组需要TIPS修正的患者百分比更低,尽管结果无统计学意义(11.1%对22.2%,p = 0.63)。

结论

原发性限制性TIPS是对传统TIPS的一种可行改良,技术和临床成功率相似。在限制性组中观察到门体压力梯度降低幅度较小及修正需求的趋势。知识进展:原发性限制性TIPS允许对分流直径进行更大程度的逐步控制,可能是一种对有肝性脑病风险患者的改良技术。

相似文献

1
Primary constrained TIPS for treating refractory ascites or variceal bleeding secondary to hepatic cirrhosis.用于治疗肝硬化继发难治性腹水或静脉曲张出血的原发性经颈静脉肝内门体分流术。
Br J Radiol. 2018 Feb;91(1083):20170409. doi: 10.1259/bjr.20170409. Epub 2017 Dec 15.
2
Incrementally Expandable Transjugular Intrahepatic Portosystemic Shunts: Single-Center Experience.逐步扩张经颈静脉肝内门体分流术:单中心经验。
AJR Am J Roentgenol. 2018 Feb;210(2):438-446. doi: 10.2214/AJR.17.18222. Epub 2017 Dec 20.
3
The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.经颈静脉肝内门体分流术(TIPS)在门静脉高压症治疗中的作用。
J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S344-51. doi: 10.1097/MCG.0b013e318157e500.
4
Transjugular intrahepatic portosystemic shunt (TIPS) placement at index portal hypertensive decompensation (anticipant TIPS) in cirrhosis and the role of early intervention in variceal bleeding and ascites.经颈静脉肝内门体分流术(TIPS)在肝硬化指数性门脉高压失代偿(预期 TIPS)中的应用,以及早期干预对静脉曲张出血和腹水的作用。
Indian J Gastroenterol. 2021 Aug;40(4):361-372. doi: 10.1007/s12664-021-01179-3. Epub 2021 Jul 29.
5
Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.100例患者经颈静脉肝内门体分流术治疗静脉曲张出血后的结局
Am J Gastroenterol. 1997 Sep;92(9):1444-52.
6
Technical success and outcomes in pediatric patients undergoing transjugular intrahepatic portosystemic shunt placement: a 20-year experience.经颈静脉肝内门体分流术治疗小儿患者的技术成功率及疗效:20年经验总结
Pediatr Radiol. 2019 Jan;49(1):128-135. doi: 10.1007/s00247-018-4267-9. Epub 2018 Oct 6.
7
The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.自发性门体分流的存在会增加经颈静脉肝内门体分流术(TIPS)置入术后并发症的风险。
Diagn Interv Imaging. 2016 Jun;97(6):643-50. doi: 10.1016/j.diii.2016.02.004. Epub 2016 Mar 2.
8
Transjugular Intrahepatic Portosystemic Shunt (TIPS): Pathophysiologic Basics, Actual Indications and Results with Review of the Literature.经颈静脉肝内门体分流术(TIPS):病理生理学基础、实际适应症及结果并文献综述
Rofo. 2018 Aug;190(8):701-711. doi: 10.1055/a-0628-7347. Epub 2018 Jul 25.
9
Second prophylaxis of variceal bleeding in cirrhotic patients with a high HVPG.对肝静脉压力梯度(HVPG)较高的肝硬化患者进行静脉曲张出血的二级预防。
Scand J Gastroenterol. 2016 Dec;51(12):1502-1506. doi: 10.1080/00365521.2016.1193218. Epub 2016 Jul 5.
10
Technical Feasibility and Clinical Effectiveness of Transjugular Intrahepatic Portosystemic Shunt Creation in Pediatric and Adolescent Patients.经颈静脉肝内门体分流术在儿童和青少年患者中的技术可行性及临床疗效
J Vasc Interv Radiol. 2019 Feb;30(2):178-186.e5. doi: 10.1016/j.jvir.2018.10.003.

引用本文的文献

1
The transjugular intrahepatic portosystemic shunt: Smaller stent diameters are required to optimize pressure response.经颈静脉肝内门体分流术:需要更小的支架直径来优化压力反应。
ILIVER. 2023 May 27;2(2):89-96. doi: 10.1016/j.iliver.2023.05.004. eCollection 2023 Jun.
2
IR management of portal hypertension complications.门静脉高压并发症的介入放射学管理
Clin Liver Dis (Hoboken). 2023 Sep 2;22(2):75-79. doi: 10.1097/CLD.0000000000000077. eCollection 2023 Aug.
3
Transjugular Intrahepatic Portosystemic Shunt Placement: Entering the Era of Controlled Expansion.经颈静脉肝内门体分流术:进入可控扩张时代。
Cardiovasc Intervent Radiol. 2023 Jun;46(6):823-824. doi: 10.1007/s00270-023-03450-w. Epub 2023 May 3.
4
How Controlled is the Expansion of VIATORR CX?VIATORR CX 的扩张可控吗?
Cardiovasc Intervent Radiol. 2023 May;46(5):658-663. doi: 10.1007/s00270-023-03383-4. Epub 2023 Feb 24.
5
Hepatic Venous Pressure Gradient.肝静脉压力梯度
Clin Liver Dis (Hoboken). 2021 Apr 13;17(3):144-148. doi: 10.1002/cld.1031. eCollection 2021 Mar.
6
Current Management of Intestinal Stomas and Their Complications.肠造口及其并发症的当前管理
J Anus Rectum Colon. 2020 Jan 30;4(1):25-33. doi: 10.23922/jarc.2019-032. eCollection 2020.
7
Laparoscopic totally extraperitoneal (TEP) inguinal hernia repair in patients with liver cirrhosis accompanied by ascites.肝硬化伴腹水患者的腹腔镜完全腹膜外(TEP)腹股沟疝修补术。
Medicine (Baltimore). 2019 Oct;98(43):e17078. doi: 10.1097/MD.0000000000017078.

本文引用的文献

1
Observational cohort study of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS).经颈静脉肝内门体分流术(TIPS)后肝性脑病的观察性队列研究。
Ann Hepatol. 2017 Jan-Feb;16(1):140-148. doi: 10.5604/16652681.1226932.
2
Pathological Predictors of Shunt Stenosis and Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt.经颈静脉肝内门体分流术后分流狭窄和肝性脑病的病理预测因素
Biomed Res Int. 2016;2016:3681731. doi: 10.1155/2016/3681731. Epub 2016 Nov 15.
3
Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites.经颈静脉肝内门体分流术联合覆膜支架增加肝硬化并复发性腹水患者的无移植生存率。
Gastroenterology. 2017 Jan;152(1):157-163. doi: 10.1053/j.gastro.2016.09.016. Epub 2016 Sep 20.
4
Evaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions.肝性脑病的评估与管理:现状与未来方向
Gut Liver. 2016 Jul 15;10(4):509-19. doi: 10.5009/gnl15419.
5
The Evolution of Transjugular Intrahepatic Portosystemic Shunt: Tips.经颈静脉肝内门体分流术的发展:技巧
ISRN Hepatol. 2014 Mar 18;2014:762096. doi: 10.1155/2014/762096. eCollection 2014.
6
Construction of Transjugular Intrahepatic Portosystemic Shunt: Bare Metal Stent/Stent-graft Combination versus Single Stent-graft, a Prospective Randomized Controlled Study with Long-term Patency and Clinical Analysis.经颈静脉肝内门体分流术的构建:裸金属支架/覆膜支架组合与单覆膜支架对比,一项关于长期通畅性和临床分析的前瞻性随机对照研究
Chin Med J (Engl). 2016 Jun 5;129(11):1261-7. doi: 10.4103/0366-6999.182830.
7
The Transjugular Intrahepatic Portosystemic Shunt: Technique and Instruments.经颈静脉肝内门体分流术:技术与器械
Tech Vasc Interv Radiol. 2016 Mar;19(1):2-9. doi: 10.1053/j.tvir.2016.01.001. Epub 2016 Jan 28.
8
Quality Improvement Guidelines for Transjugular Intrahepatic Portosystemic Shunts.经颈静脉肝内门体分流术质量改进指南
J Vasc Interv Radiol. 2016 Jan;27(1):1-7. doi: 10.1016/j.jvir.2015.09.018. Epub 2015 Nov 21.
9
Transjugular intrahepatic portosystemic shunt complications: prevention and management.经颈静脉肝内门体分流术并发症:预防与处理
Semin Intervent Radiol. 2015 Jun;32(2):123-32. doi: 10.1055/s-0035-1549376.
10
Primary creation of an externally constrained TIPS: a technique to control reduction of the portosystemic gradient.外部受限经颈静脉肝内门体分流术的初步创建:一种控制门体静脉压力梯度降低的技术。
AJR Am J Roentgenol. 2015 Apr;204(4):868-71. doi: 10.2214/AJR.14.13104.